Cartilage support implants for nasal valve support and delivery systems are described. The cartilage support implant can include one or more elongate bodies comprising one or more anchors. The cartilage support implant can be designed to be a permanent implant extending along the midline of a patient's nose, from the nasal bone to the lower lateral cartilage. Methods of placing the cartilage support implant and retrieving the cartilage support implant are also described.

A nasal dilator comprises magnets. The nasal dilator is a set comprising two bodies. Each of the two bodies has a first leg having at a distal portion thereof a magnet; and a second leg connected to the first leg via a bridge comprising flexible material. Each of the two bodies are designed so as to allow said body to be clamped to an ala nasi of a human nose between the distal portions of said first leg and said second leg. The magnets of the bodies are aligned such that with a body clamped to the ala nasi of a nose, the magnet is oriented at an angle to a plane defined by the ala nasi area clamped between said two distal portions of said first leg and second leg. Thanks to the repelling action of the magnets, the alae nasi are pushed apart, resulting in improved ease of breathing.

Nasal implants are provided that have a planar type profile with open spaces through portions of the planar type profile. The nasal implant can be compressible along one or more dimensions of the nasal implant, such as the width and length of the planar type profile. Delivery tools for deploying the nasal implants within the nasal tissue are also provided. Methods for deploying the nasal implants within the nasal tissue of the patient are also provided.

This disclosure describes, inter alia, materials, devices, kits and methods that may be used to treat chronic sinusitis.

An implant device for non-surgically repairing and augmenting internal nasal valve ligaments of a patient. The device is configured for tunneling a subcutaneously into the ligaments of the nasal valve and the surrounding soft tissues and periosteum of the adjacent bony structures, causing a tightening of the nasal valve ligaments and repositioning the nasal valve in adjustable fashion. The device comprises a barbed elongate implant that is introduced by tunneling subcutaneously into the nasal valve ligament allowing for structural re-positioning of the nasal valve cartilage structures and tightening of the ligaments, which is adjustable intra-operatively and allows for structural support of the nose and/or causes a change in the external shape of the nose.

Described here are paranasal sinus devices for treating paranasal sinus conditions. The devices include a cavity member, ostial member, and nasal portion. One or more of the cavity member, ostial member, and nasal portion may deliver an active agent for sustained release to treat the paranasal sinus condition. Exemplary paranasal sinus conditions are sinus inflammation due to functional endoscopic sinus surgery (FESS) and rhinosinusitis.

There is provided herein a bone anchored implant that is used to support a nasal prosthesis in patients with a missing external nose. The implant consists of central section (which is preferably generally triangular) suspended within the aperture of the nasal cavity by four fixation arms which extend radially to engage the surrounding maxillary bone. The triangular portion may support three fixation points, one at each corner of the triangular portion, which in turn, directly engage the nasal prosthesis either via magnets or mechanical locking interface. Extending radially from the triangular section, the four fixation arms may flatten to a clover leaf arrangement of three apertures which accommodate micro-screws that secure the implant to the surrounding maxillary bone.

A system and method for maintaining a patent paranasal sinus ostium includes delivering a tubular element in an insertion state to the sinus ostium. The tubular element includes a proximal end, a distal end, and a center region between the proximal end and the distal end. The method includes expanding the tubular element from the insertion state to a deployment state when the tubular element is located in the sinus ostium. In the deployment state, the center region confronts the sinus ostium with an outward radial force. Other embodiments are disclosed.

Systems and methods for deploying a stent within the frontal sinus. The stent includes flexible foam and film layers arranged in a stacked configuration and furled within a cartridge prior to deployment. The cartridge is removably coupled to an applicator device including an actuator. The film layer may include a polymer having a resilience sufficient to unfurl the stent and maintain patency of the frontal sinus opening. The flexible foam layer may have porosity of greater than 80%, and an active agent may be within the flexible foam layer. The flexible foam layer may be bioresorbable and the flexible film layer biocompatible and non-biodegradable. The stent may include first and second body portions with the first body portion independently unfurling from the second body portion to retain the stent within the frontal sinus. Contouring of the first and second body portions may facilitate ease with removal of the stent.

Described are implants for placing in a body, tools for delivering the implants, and systems and methods for using implants and tools for placing in a body and more particularly to nasal implants, tools for delivering nasal implants, and systems and methods for using such implants and tools. A tool may include a hand-held implant delivery device that holds, moves, orients, inserts, or shapes an implant. An implant may be a biodegradable, longitudinal implant that may be oriented for implantation by an implant delivery device.